Muco Rhinathiol Kinderen (Carbocisteine)

Carbocisteine reduces mucus viscosity by breaking disulfide bonds within mucopolysaccharide fibers. This chemical modification makes the secretions less sticky and easier for cilia and cough effort to move, thereby improving clearance from the bronchial tree and alleviating cough.

The dose of carbocisteine for children is determined by the prescribing healthcare professional based on the child’s age, weight, and clinical condition. The prescriber will provide specific instructions on how much to give and how often.

Safety data for carbocisteine during pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine primarily reduces mucus viscosity by cleaving disulfide bonds, whereas ambroxol stimulates surfactant production and enhances ciliary activity. Both improve mucus clearance, but carbocisteine is often preferred for its direct mucolytic action in pediatric formulations, while ambroxol may have a broader bronchodilatory effect.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The medication is taken orally, usually as a syrup or liquid preparation. It should be measured with a calibrated device and given according to the prescriber’s instructions, typically with or without food depending on the specific guidance.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, hepatic injury, blood disorders such as neutropenia, and bronchospasm. Immediate medical attention is required if any of these occur.

Children with a known hypersensitivity to carbocisteine or any other component of the formulation should avoid its use. Additionally, it is contraindicated in patients with severe renal impairment unless dose adjustments are made, and it should be used cautiously in those with uncontrolled asthma.